Konica Minolta to Pay Up to $1 Billion for Ambry

Ambry’s founder had vision to offer value with full gene sequencing, genetic counselors

CEO SUMMARY: It’s the second time in six years that a Japanese corporation paid a high price for a genetic testing company in the United States. Konica Minolta will purchase Ambry Genetics for $800 million at closing and $200 million upon hitting certain financial metrics. In 2011, Miraca Holdings acquired Caris Life Sciences for $725 …

Konica Minolta to Pay Up to $1 Billion for Ambry Read More »

This post is only available to members.



You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.